您当前的位置: > 详细浏览

我国预印本平台发展现状及对策研究

Development Status and Countermeasures of Preprint Platform in China

摘要:预印本具有交流速度快、利于学术交流、时效性强的特点,打破了以期刊为中心的科学交流体系,实现了科研工作者及时交流、互动共享的愿景,重构与再造了更加开放的现代科学交流体系,新冠大流行对知识快速获取及分享的迫切需求极大地促进了预印本的发展。目前我国创建的预印本平台共4个,其中ChinaXiv是国内第一个按国际通行模式规范运营的预发布平台,CSPO发文数量最多,已超10万篇,biomedRxiv是国内首个按国际通行模式规范运营的生物医学领域的预发布平台,创建于2004年的中国预印本服务系统发文数量仅1万多篇,增速缓慢,且网站服务有待完善。国内预印本平台存在以下问题:发文数量、质量及国内科研机构与高校认可度低;合作期刊少,不利于预印本文章后续在学术期刊的发表;评论活跃度低,学术交流互动较少。建议从加大宣传、加强内容审核、增强与期刊合作、明确预印本文章学术价值以提高科研机构与高校对其认可度等方面进行努力,推动我国预印本平台做大做强。

英文摘要:Preprint has the characteristics of fast communication, facilitating academic communication and strong timeliness. It breaks the journal centered scientific communication system, realizes the vision of timely communication, interaction and sharing among scientific researchers, reconstructs a more open modern scientific communication system, and the urgent demand for rapid knowledge acquisition and sharing of thecoronaviruspandemic has greatly promoted the development of the preprint. At present, there are four preprint platforms established in China. Chinaxiv is the first preprint platform operating in accordance with the international prevailing model. CSPO has issued the largest number of documents, exceeding 100 000. Biomedrxiv is the first preprint platform in the biomedical field operating in accordance with the international prevailing model. Chinese Preprint Service System established in 2004 has issued only more than 10 000 documents, with a slow growth rate, and the website service needs to be improved. The domestic preprint platforms have the following problems: low quantity and quality of documents and low recognition of domestic scientific research institutions and universities; There are few cooperative journals, which is not conducive to the subsequent publication of preprinted articles in academic journals; Low activity of comments and less academic exchange and interaction. It is suggested that efforts should be made to increase publicity, strengthen content review, enhance cooperation with journals, clarify the academic value of preprinted articles, and improve the recognition of scientific research institutions and universities, so as to promote the expansion and strengthening of China's preprinted platform.

版本历史

[V1] 2022-09-21 12:06:23 chinaXiv:202209.00134V1 下载全文
点击下载全文
同行评议状态
待评议
许可声明
metrics指标
  • 点击量3935
  • 下载量73
评论
分享
邀请专家评阅